Brown adipose tissue (BAT) activation increases glucose and lipid consumption; 55 as such, it is been considered as a potential therapy to decrease obesity. BAT is 56 highly vascularized and its activation is associated with a necessary increase in 57 blood flow. However, whether increasing BAT blood flow per se increases BAT 58 activity is unknown. To examine this hypothesis, we investigated whether an 59 
INTRODUCTION 89
necessary both to provide enough oxygen and substrates for thermogenesis and 114 to avoid thermal injury (15, 36) . However, the impact of an increase in BAT 115 blood flow per se on BAT activation has never been studied. 116 We hypothesized that increasing BAT blood flow would lead to an 117 increased BAT substrate availability and uptake and thus result in BAT 118 activation. Stimulation of glucose uptake by an increase in muscle blood flow has 119 been described in several studies in the skeletal muscle in vivo in humans (6, 12, 120 51). In these studies, investigators reported that physiological stimuli such as 121 insulin or exercise induced an increase in muscle blood flow that was 122 responsible, at least in part, for the muscle glucose uptake increase (6). In 123 addition, increasing muscle blood flow with a non-physiological stimulus such as 124 methacholine infusion during either a high-or low-dose insulin clamp also 125 enhanced glucose uptake (3). 126
Although they are not expressed in isolated brown adipocytes, β2-AR are 127 detected in the BAT, leading to the hypothesis that β2-AR might only be present 128 in BAT blood vessels (8). Despite the absence or low expression of β2-AR gene 129 expression in isolated brown adipocytes, β2-AR gene expression levels in human 130
BAT are higher than β1-AR and β3-AR gene expression levels (19) . 131
MATERIAL AND METHODS 137 138
Mice 139
All animal studies were performed according to a written protocol approved by 140 the Massachusetts General Hospital Subcommittee on Research Animal Care, and 141
were conducted in accordance with the Guide for the Care and Use of Laboratory 142
Animals (33). 143
Ten to twelve-week-old male C57BL6 mice (Jackson Laboratory, Bar Harbor, 144 ME) were studied. All animals were fed a standard diet (11.8% kcal from fat; 145
Prolab Isopro RMH 3000 5P75, LabDiet, Richmond, IN) and maintained on a 146 standard 12-hour light/12-hour dark cycle with food and water given ad libitum 147 until the experiments. 148
Beta 2-AR stimulation was obtained using acute administration of a widely used 149 β2-AR selective agonist, salbutamol (27). Salbutamol was obtained from Sigma 150
Aldrich (S8260) and diluted in sterile 0.9% saline before injection. 151
152

BAT tissue perfusion assessment by contrast ultrasound 153
Brown adipose tissue perfusion was assessed by measuring BAT blood flow 154 using contrast ultrasound as previously described (5, 13). Briefly, mice were 155 anesthetized with an intraperitoneal injection of ketamine (100 mg/kg) and 156 xylazine (10 mg/kg). After orotracheal intubation, animals were mechanically8 catheter) was surgically placed for continuous invasive measurement of mean 162 blood pressure and heart rate. Similarly, catheters were placed in the left and 163 right jugular veins and used for intravenous infusions of salbutamol and 164 ultrasound contrast agent respectively. 165
Ultrasound acquisition 166
Acquisitions were performed in the prone position using a commercially 167 available ultrasound system with a 14-MHz linear transducer (Acuson Sequoia 168 C512; Siemens Medical Solutions USA, Inc., Mountain View, CA). Perflutren lipid 169 microbubbles (Definity; Lantheus Medical Imaging, Inc., North Billerica, MA) 170 were diluted in sterile 0.9% saline solution (1:10) and continuously infused 171
intravenously at a rate of 20 μL/min into the right jugular vein. For each 172 acquisition, images centered on the BAT were acquired during 10 seconds after a 173 burst of 10 high-energy frames (mechanical index: 1.8). The first set of 174 acquisitions was performed 10 minutes after the onset of microbubbles 175
perfusion. An intravenous infusion of 0.2 μg/kg.min of salbutamol was then 176 initiated and the second set of acquisitions was performed 10 minutes later. 177
BAT tissue perfusion analysis 178
Regions of interest were traced manually within the two BAT interscapular lobes 179 (5, 13). The average signal intensity within the region of interest was 180 automatically measured for each frame (syngo ACQ; Siemens Medical Solutions 181 USA, Inc.). The relationship of the signal intensity over time after bubble 182 destruction was obtained in each region of interest and fitted to an exponential 183 function: y = A (1-e βt ) where y is the signal intensity, A is the plateau intensity, 184 and β is the initial slope of the replenishment curve. Blood flow was estimated by 185 calculating the product of A and β (52) . A minimum of three measurements was 186 averaged. A goodness-of-fit coefficient (R 2 of the fit) was obtained for each curve, 187
and an arbitrary threshold of 0.8 was set. All curves with a goodness-of-fit <0.8 188 were excluded. 189 Brown adipose tissue lobes were digested in 2 steps using decreasing doses of 212 collagenase (26). To that purpose, the buffer was changed to 3 mL with 1.3 mg/ 213 mL collagenase II, and the tissue was incubated in a slowly shaking water bath at 214 37 °C with vortexing every minute. After 7 min, the buffer was discarded, and the 215 tissue was placed in 6 mL of fresh buffer with 0.67 mg/ mL collagenase II, Brown adipose tissue blood flow, blood pressure, heart rate and cardiac 287 output before and during salbutamol infusion were compared using paired t-288 tests. Comparison of β2-AR gene expression in isolated brown adipocytes and 289 BAT was performed using an unpaired t-test. Maximal oxygen consumption of 290 isolated brown adipocytes at baseline, with salbutamol and with norepinephrine 291 was compared using ANOVA for repeated measurements. If the effect of 292 treatments (ANOVA) was significant, the treatments were compared to baseline 293 conditions and to each other using paired t-tests. The difference in BAT and 294 white adipose tissues glucose uptake between mice with salbutamol and saline 295 injection was tested by unpaired t-test. 296
All tests were two-tailed and a P value < 0.05 was considered significant. decreased from 79 ± 3 mmHg to 65 ± 4 mmHg (P=0.008) whereas the heart rate 307 remained stable (386 ± 13 bpm and 387 ± 12 bpm at baseline and during 308 salbutamol infusion respectively). 309
In order to evaluate whether an increase in cardiac output was 310 responsible for the BAT perfusion response, the effect of salbutamol infusion on 311 cardiac output was tested in a separate set of mice (n=6). A slight increase in 312 cardiac output was observed (9.6 ± 0.8 vs. 11.5 ± 0.7 mL/min at baseline 313 compared with salbutamol infusion; P=0.04). The mean percentage change in 314 cardiac output between baseline and salbutamol infusion was of 25 ± 10%. 315
316
Beta 2 adrenoreceptor expression in isolated brown adipocytes and brown 317 adipose tissue 318
Expression of β2-AR and UCP1 was assessed in isolated brown adipocytes and 319 total BAT by RT-PCR. As expected, β2-AR mRNA expression level was extremely 320 low in isolated brown adipocytes whereas a significant expression was found in 321 total brown adipose tissue (Figure 2A ). UPC1 gene expression was higher in 322 isolated cells as compared to brown adipose tissue ( Figure 2B) . Similarly, we reported a decreased BAT capillary density in a genetic murine 366 model of obesity (db/db mice) (13) . These data suggest that BAT vascularization 367 and blood flow play a major role in the function of BAT and in the association 368 between BAT dysfunction and obesity. 369
Vasculature in BAT might be different than that of other tissues. Our team 370 (5) and others (21) previously reported that norepinephrine induces a 371 significant increase in BAT blood flow. Vascular response to norepinephrine is 372 dependent to the predominance of β-or α-AR (α1/ β2 ratio) in the vessels. A 373 norepinephrine induced-vasodilation is observed in specific tissues with β-AR 374 predominance such as the iliac arteries (50) whereas an important 375 norepinephrine induced-vasoconstriction is observed in the vast majority of 376 tissues and is related to the α-AR predominance (49). Therefore, we can 377 hypothesize that β2-AR might be predominant as compared to α1-AR in the BAT 378
vasculature. 379
The present study demonstrates the importance of BAT perfusion in 380 rodents: the vascularity of BAT in humans may be less homogeneous as BAT 381 depots are not as well delineated as in rodents (30, 31) . Nonetheless, BAT 382 perfusion in humans is significant, being twice that of muscle in warm conditions 383 and increasing to 4 times that of muscle when cold-stimulated (36) . Similarly, 384 our data was obtained in rodents, in which the importance of BAT for glucose 385 regulation is crucial (43, 45). In humans, several studies suggest that activated 386 BAT has the ability to remove glucose from circulation but whether this response 387 is clinically relevant is still debated (42). Recent data suggest that this response 388 may in certain cases at least be clinically relevant, as stimulation of BAT in 389 human volunteers with detectable BAT (using 18 FDG PET/CT scanning) increases 390 insulin sensitivity (10). 391
We used salbutamol, a selective β2-AR agonist (27) Selective β2-AR stimulation (using salbutamol) increased BAT glucose 427 uptake whereas no effect on WAT glucose uptake was observed. A dose of 10 428 μg/g body weight was chosen based on previous reports of active doses of 429 salbutamol in other indications in murine model (11, 24) . Salbutamol induced a 430 7-fold increase in BAT glucose uptake whereas a previous study reported a 2-431 fold increase after 0.2 mg/kg norepinephrine intraperitoneal injection (22) . 432
Assessment of BAT activity is challenging. BAT glucose uptake is 433 imperfect but has been recognized as a marker of BAT activity in previous 434 publications (17, 25, 34). In addition, direct assessment of thermogenesis is 435 challenging and would not have reflected only BAT activity but also vasodilation 436 induced by β2-AR stimulation in our study. 437
In humans, β2-AR agonists such as salbutamol increase both glucagon and 438 insulin secretion and have effects on liver metabolism, which cause an overall 439 increase in blood glucose level (37). In rat isolated islets of Langerhans, the β2-440 AR agonist clenbuterol induced a rise in glucagon secretion whereas no direct 441 effect on insulin secretion was observed (23). The potential impact of salbutamol 442 on glucose homeostasis might be involved in the BAT increased glucose uptake 443 that we observed. This hypothesis is counterbalanced by the fact that no increase 444 in WAT glucose uptake was observed in the same conditions. Furthermore, it has 445 been recently shown that acute β2-AR stimulation by salbutamol has no effect on 446 skeletal muscle glucose uptake (29) . increase BAT blood flow. In addition, a positive association between the whole 452 body energy expenditure and BAT blood flow was reported in humans (36) . 453
Conversely, when the response of BAT blood flow to norepinephrine is inhibited, 454 the thermogenic ability of BAT is suppressed (32). As in many other tissues, it is 455 likely that blood flow increases in response to an increased metabolic demand. 456
The present study demonstrates the distinct and reciprocal finding that an 457 increase in BAT blood flow induces an increase in BAT metabolic activity. 458
The mechanism by which an increase in tissue blood flow stimulates 459 glucose uptake is unknown; in muscles, it may involve an increase in glucose salbutamol is a selective β2-AR agonist but a marginal effect on β1-AR cannot be 477
excluded. 478
During in vivo experiments, salbutamol infusion was associated with a 479 slight decrease in mean blood pressure (from 79 ± 3 mmHg to 65 ± 4 mmHg, 480 P=0.008). Therefore, the potential influence of the baroreflex, including a 481 systemic increase in sympathetic activity that may stimulate BAT, cannot be 482 completely excluded even though the decrease in blood pressure was small and 483 no increase in heart rate was noted. 484
Despite the routine use of BAT glucose uptake as a marker of BAT activity 485 in clinical studies using 18 F-FDG-PET/CT, glucose is not the only substrate used 486 for thermogenesis and may underestimate the thermogenic activity (16). In 487 addition, glucose uptake by BAT endothelial cells (as opposed to uptake by 488 brown adipocytes) cannot be excluded using this technique. 489
The kinetics of the increase in blood flow and glucose uptake were not 490 assessed during the same experiment. Therefore, we cannot determine whether 491 the glucose uptake increase lasted only as long as the blood flow increase. 
